Linden Capital Partners has promoted Michael Farah to Partner and Kam Shah to Principal. The firm has also hired Michael Bernard and Max Gaby as new Vice Presidents.
Linden is focused exclusively on leveraged buyouts in the healthcare and life science industries. The firm’s strategy is based upon three elements: healthcare and life science industry specialization; integrated financial and operating expertise; and strategic relationships with large corporations.
“Our team has prevailed in partnering with premier businesses by following our disciplined approach of focusing on key healthcare sectors and integrating the expertise of operating executives and investment professionals,” said Linden President and Managing Partner Tony Davis. “On behalf of the partnership, we are thrilled to recognize the performance of the team and welcome our newest teammates as we successfully execute the Linden strategy.”
Mr. Farah, who joined Linden in 2014, has been active on the pharmaceutical services and contract manufacturing sector teams, which led to investments in Flexan Corporation and ProPharma Group. He started his career in the healthcare investment banking group at UBS, spent three years as a private equity associate with Summit Partners, followed by six years at Metalmark Capital focused on healthcare investing. Mr. Farah has a BS in Business Administration from Carnegie Mellon and an MBA from Harvard.
Mr. Shah joined Linden in 2009 as an associate and returned as a vice president in 2013 after completing business school. Prior to Linden, he was a private equity associate at Sun Capital Partners. He began his career as an investment banking analyst at Goldman Sachs, where he focused on M&A advisory, capital raising, and leveraged buyout transactions. Mr. Shah has a BS in Finance from the University of Illinois and an MBA from Stanford.
Mr. Bernard has been involved in principal investing and investment banking since 2007. He joins Linden from 3i Group where he spent the last two years focused on healthcare investing. He started his career at Morgan Stanley in the leveraged loan investment group before joining the healthcare investment banking group. Mr. Bernard has a BA in Economics from Brown University and an MBA in Health Enterprise Management from Northwestern University.
Mr. Gaby has been involved in principal investing and investment banking since 2010. Prior to Linden, Mr. Gaby served as a private equity associate with GTCR and began his career as an investment banking analyst at Bank of America Merrill Lynch. Mr. Gaby has a BS in Finance and International Studies from Georgetown University and an MBA from The University of Chicago.
This has been a very busy year for Linden. In 2016, the firm has closed on three platform investments, three portfolio add-on acquisitions, sold Corpak MedSystems to Halyard Health, and completed dividend recapitalizations at Young Innovations and Spear Education.
Linden Capital Partners is based in Chicago (www.lindenllc.com).
© 2016 Private Equity Professional • 10-28-16
